Elsevier partners with ASTS and AST to publish American Journal of Transplantation

Thursday, July 21, 2022

Elsevier partners with the American Society of Transplant Surgeons and the American Society of Transplantation to publish American Journal of Transplantation

Collaboration signifies strong commitment by all stakeholders to maintain the journal’s high standards and expand its global prominence.

The American Society of Transplant Surgeons and the American Society of Transplantation and Elsevier, a global leader in research publishing and information analytics, are delighted to announce a new partnership to publish the American Journal of Transplantation (AJT). The journal will also offer authors an open access option and will be hosted on Elsevier’s leading online platform, ScienceDirect, beginning January 2023.

The AJT was founded in 2000 and has since grown into the premier journal in transplantation. It serves as a forum for debate and reassessment, an agent of change, and a major platform for promoting understanding, improving results, and advancing science in the dynamic field of transplantation. Published monthly, the American Journal of Transplantation provides an essential resource for researchers and clinicians around the world.

AST President, Deepali Kumar, MD MSc FRCPC FAST, said: “We welcome Elsevier as our new publisher and look forward to working together, leveraging their publishing expertise and commitment to education and innovation as we continue to increase the visibility and influence of the AJT.”

ASTS President Will Chapman, MD, FACS, said, “We are excited to partner with Elsevier to maintain AJT’s high quality and standing as the place where our members publish their most exciting research. With Elsevier’s broad range of journals and experience, AJT will be in good hands as the publishing landscape continues to evolve.”

AJT’s eminent editorial board, under the continued leadership of Editor-in-Chief Sandy Feng, MD MSc FRCPC FAST, ensures that this high quality, peer-reviewed journal will continue to be an authoritative resource for the dissemination of transplantation research.